Profile for Poland Patent: 3212237
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Poland Patent: 3212237
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,129,833 | Oct 28, 2035 | Shorla | JYLAMVO | methotrexate |
| 11,771,701 | Oct 29, 2034 | Shorla | JYLAMVO | methotrexate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
